Pregnancy Complications in a-Thalassemia (Hemoglobinopathy H): A Case Study

Thalassemia intermedia (TI) is a clinical definition which represents a wide spectrum of thalassemia genotypes but mainly includes patients who do not require or only occasionally require transfusion. An uncommon case of a 32-year-old Greek woman, para 1, at the 22nd week + day 3 of gestation with t...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in obstetrics and gynecology 2018, Vol.2018 (2018), p.1-4
Main Authors: Vlahos, Nikos F., Tsaroucha, Athanasia, Triantafyllou, Faidra-Evangelia, Valsami, Serena, Efstathopoulou, Maria, Dryllis, Giorgos, Politou, Marianna, Kattamis, Antonis
Format: Article
Language:English
Subjects:
Abdomen
Anemia
Anticoagulants (Medicine)
Biochemistry
Blood
Blood clot
Case Report
Case reports
Case studies
Complications and side effects
Enzymes
Family medical history
Gynecology
Health risk assessment
Hematology
Mutation
Obstetrics
Patients
Pregnancy
Pregnancy complications
Pregnant women
Thalassemia
Thromboembolism
Thrombosis
Ultrasonic imaging
Veins & arteries
Womens health
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Thalassemia intermedia (TI) is a clinical definition which represents a wide spectrum of thalassemia genotypes but mainly includes patients who do not require or only occasionally require transfusion. An uncommon case of a 32-year-old Greek woman, para 1, at the 22nd week + day 3 of gestation with thalassemia intermedia (she was splenectomized), where her pregnancy was complicated with portal vein thrombosis, splenic thrombosis, and partial HELLP, is described. This is a generally uncommon event in thalassemia intermedia. She had no transfusion as her hematologist consulted and she took anticoagulation therapy. Thus, we present for the first time in the literature a case of HbH a-thalassemia pregnant woman whose pregnancy was complicated with portal vein thrombosis, splenic vein thrombosis, and partial HELLP; she was treated with anticoagulation therapy and she had a successful outcome.
ISSN:2090-6684
2090-6692
DOI:10.1155/2018/8532081